Regional Central Database Recording of Chronic Myeloid Leukemia

• Conditions: Chronic Myeloid Leukemia

• Registration Number: NCT02869256
• Lead Sponsor: Institut Bergonié

Brief Summary

It will be a centralized database , multicentre (6 centers) , regional, chronic myelogenous leukemia cases of registration (CML) prospectively and retrospectively.

Detailed Description

Given the complexity and evolution of recommendations and to harmonize these, it appears necessary to establish a central database for recording , monitoring patients with CML supported by the participating centers the region and evaluation of care practices in use .

Indeed , the main purpose of this database is to provide diagnostic and therapeutic management of reported cases of chronic myeloid leukemia and to study the prognostic factors . The main objective is to improve significantly the percentage of patients treated adequately load in the region, in the initial stages of the disease and during its evolution.

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2016-08-09
• Study First Submitted QC: 2016-08-11
• Study First Posted: 2016-08-16
• Status Verified: 2017-11
• Last Update Submitted: 2017-11-17
• Last Update Posted: 2017-11-21
• Primary Completion: 2024-01
• Study Completion: 2024-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• chronic myeloid leukemia Diagnosis (CML) in chronic phase , accelerated or blast
• male or female patient aged 18 years or more
• Cases transmitted by referring hematologist , one of the 6 participating centers after patient's oral information
• Clinical record presented Concertation Meeting LMC Multidisciplinary coordinated by the Institute Bergonié

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
compliance of the management of patients with chronic myeloid leukemia compared to the guidelines	10 years

Secondary Outcome Measures

Name	Time	Method
overall survival	10 years

Trial Locations

Locations (6)

Institut Bergonié; 🇫🇷 Bordeaux, France

Centre Hospitalier Universitaire de Pau; 🇫🇷 Pau, France

Polyclinique Bordeaux Nord; 🇫🇷 Bordeaux, France

Centre Hospitalier Universitaire de Bordeaux; 🇫🇷 Bordeaux, France

Centre Hospitalier Universitaire de Dax; 🇫🇷 Dax, France

Centre hospitalier Libourne; 🇫🇷 Libourne, France